Do U.S. private label buyers need FDA cosmetic product listing under MoCRA for body care?

Yes—most U.S. private label body-care products sold in the U.S. fall under MoCRA, and the U.S. “Responsible Person” typically must submit FDA facility registration and product listing. As an overseas OEM/ODM, we can support the data package you’ll need, but we can’t guarantee regulatory acceptance.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • For U.S. private label body care, MoCRA generally expects FDA facility registration and cosmetic product listing, handled by the U.S.
  • Responsible Person (often the brand owner/importer or a U.S. agent you appoint).
  • If you are an Amazon seller, you should plan early for who will act as Responsible Person and maintain the product file; we can support documentation and testing inputs for that file.
  • On our side, we can provide formula/INCI details, manufacturing info, and supporting documents, and we can help arrange product testing and track the inspection report through our long-term cosmetics testing cooperation (China-based).
  • We also support concept positioning, product architecture, IFU/leaflet and price sheet drafting, plus full VI and packaging coordination.
  • Practical timeline: custom formula sampling after brief confirmation, then production.
  • Bulk production is typically 10-20 working days after final sample/pack confirmation; packaging ordering often takes 10-30 working days (e.g., glass bottle ~15 days, acrylic ~30, tube ~15, mask pouch ~15; unit box ~15, gift set ~20).
  • MOQ depends on formula and packaging; a common starting point is 1,000-3,000 units per SKU.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).